IP licensing and business: Feb. 13-26

By Nick Robertson ( February 26, 2026, 20:49 GMT | Insight) -- Licensing deals in the pharmaceutical and biotechnology industries made the most news in recent weeks, while patent pool administrator Via LA continued the growth of its automotive Qi Wireless patent pool in China.Pharmaceutical licensing deals are again the most notable, with China’s Harbour Bioscience using a unique off-shoot company to court investors for its new cancer drug candidate in a deal that could be worth up to $1.2 billion. GlaxoSmithKline also reached a deal to pay China’s Frontier Biotech up to $1 billion for its RNA drug platform....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.

Know what others in the room don’t, with features including:

Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Prepare for tomorrow’s regulatory change, today

Related Sections